Prosenex specializes in medical objective screening for peripheral neuropathy across multiple medical specialties. The company’s current portfolio of medical products and product designs is focused on addressing the unmet market needs of primary care physicians, podiatrists, neurologists, endocrinologists and occupational therapists in the screening of patients for peripheral neuropathy due to diabetes and other causes.
COMPANY OBJECTIVES
The mission of Prosenex is to develop, produce and market various medical devices for the screening of neuropathy and diabetic disorders using its proprietary technology. In addressing a worldwide epidemic, Prosenex is unique in providing critical early stage screening for advanced treatment of neuropathy and diabetic disorders. The DND can be used to objectively quantify peripheral neuropathy and re-evaluate patients in longitudinal follow up. This device can be instrumental to provide concrete screening evidence to substantiate a need for tight/tighter glucose control in a particular diabetes patient.
|
|
|
